Centiva Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,877
Closed -$659K 1403
2025
Q1
$659K Buy
5,877
+4,581
+353% +$513K 0.02% 546
2024
Q4
$120K Sell
1,296
-16,315
-93% -$1.51M ﹤0.01% 1136
2024
Q3
$1.48M Buy
17,611
+16,884
+2,322% +$1.42M 0.03% 320
2024
Q2
$49.9K Sell
727
-5,252
-88% -$360K ﹤0.01% 1448
2024
Q1
$438K Buy
5,979
+4,034
+207% +$295K 0.01% 760
2023
Q4
$158K Sell
1,945
-2,054
-51% -$166K ﹤0.01% 1022
2023
Q3
$300K Buy
3,999
+3,375
+541% +$253K 0.01% 760
2023
Q2
$48.1K Sell
624
-71,776
-99% -$5.53M ﹤0.01% 1107
2023
Q1
$6.01M Buy
72,400
+34,579
+91% +$2.87M 0.15% 71
2022
Q4
$3.25M Buy
37,821
+33,463
+768% +$2.87M 0.09% 97
2022
Q3
$269K Buy
+4,358
New +$269K 0.01% 663
2022
Q2
Sell
-27,057
Closed -$1.61M 1309
2022
Q1
$1.61M Buy
+27,057
New +$1.61M 0.03% 271
2021
Q4
Sell
-7,510
Closed -$525K 897
2021
Q3
$525K Buy
+7,510
New +$525K 0.03% 482
2021
Q2
Sell
-10,190
Closed -$659K 1143
2021
Q1
$659K Sell
10,190
-6,971
-41% -$451K 0.03% 283
2020
Q4
$1M Buy
17,161
+8,830
+106% +$515K 0.04% 153
2020
Q3
$526K Buy
8,331
+937
+13% +$59.2K 0.03% 215
2020
Q2
$569K Buy
+7,394
New +$569K 0.03% 150
2020
Q1
Sell
-22,870
Closed -$1.49M 443
2019
Q4
$1.49M Buy
22,870
+2,448
+12% +$159K 0.07% 74
2019
Q3
$1.29M Buy
20,422
+4,411
+28% +$279K 0.08% 67
2019
Q2
$1.08M Buy
16,011
+10,924
+215% +$738K 0.06% 61
2019
Q1
$331K Sell
5,087
-40,493
-89% -$2.63M 0.02% 73
2018
Q4
$2.85M Buy
45,580
+15,835
+53% +$990K 0.23% 19
2018
Q3
$2.3M Buy
+29,745
New +$2.3M 0.2% 11
2018
Q2
Sell
-300
Closed -$23K 45
2018
Q1
$23K Buy
+300
New +$23K 0.01% 17
2017
Q4
Hold
0
30